Skip to content

Savara SVRA Stock-Based Comp

Stock-Based Comp at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$4.14M-6.8%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$2.57M+19.6%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$3.11M-0.3%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$10.19M+14.9%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$4.5M-7.6%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$1.52M+26.5%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.24B+247%
Enterprise value$1.23B+235%
P/S4,808.2×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's stock-based comp?
Savara (SVRA) reported stock-based comp of $10.73M in Q1 2026.
How has Savara's stock-based comp changed year-over-year?
Savara's stock-based comp increased by 260.9% year-over-year, from $2.97M to $10.73M.
What is the long-term trend for Savara's stock-based comp?
Over 4 years (2021 to 2025), Savara's stock-based comp has grown at a 45.0% compound annual growth rate (CAGR), from $3.26M to $14.42M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.